Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 800 shares, a decline of 20.0% from the December 31st total of 1,000 shares. Approximately 0.0% of the company’s stock are sold short. Based on an […]